Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided peri-articular platelet-rich plasma injection for sacroiliac joint pain
IRCT20141023019640N4Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of platelet-rich plasma in sacroiliac joint disruption (SIJD), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pain intensity at 3 months and Functional improvement at 3 months. Started Sep 2024; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
sacroiliac joint disruption (SIJD)
Beyond the preview
Go deeper on IRCT20141023019640N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141023019640N4.